[333 Pages Report] The global pupillometer market is projected to have a moderate-paced CAGR of 7.7% during the forecast period. The current valuation of the pupillometer market is US$ 385.56 Million in 2023. The value of the pupillometer market is anticipated to reach a high of US$ 809.56 Million by the year 2033.
This growth in the sales of pupillometer is supported by the following:
| Attribute | Details |
|---|---|
| Market Value (2023) | US$ 385.56 Million |
| Market Value (2033) | US$ 809.56 Million |
| CAGR | 7.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
When comparing digital and video pupillometers, the latter is clearly superior. To give just one example, these tools can record the full range of pupillary responses. In addition, video pupillometers like Konan Medical USA Inc.'s EyeKinetix pupillometer use infrared high-definition video cameras to record the bilateral pupil responses to monocular visual stimuli.
Additionally, EyeKinetix captures both spontaneous and evoked pupillary light reactions at the same time. Another element contributing to increased interest in video automated pupillometer is their recent regulatory clearance. So, in July 2021, NeurOptics Inc. introduced the NPi-300 Pupillometer to consumers in the United States. The NPI-300 Pupillometer also contains cutting-edge technologies like an LED light source, a high-precision infrared camera, and a powerful microprocessor. As a result, the market expands as a result of the increased demand brought about by these features.
In addition, video pupillometers like the NPi-300 are faster and more convenient than digital pupillometers. Therefore, automatic pupillometers eliminate the potential for human error that might occur with manual approaches. Consequently, this causes an increase in demand for video pupillometers, which in turn propels the development of the market. Therefore, because of these benefits, these devices are widely used in clinical practice.
The pupillometer market is expanding as a result of the widespread use of computers and the Internet in the creation of brand-new goods. For instance, in 2017, Essilor Instruments USA introduced the X81705 Pupillometer medical device, which combines precise measurement with user-friendly controls. Binocular and monocular measures, as well as the X81705's infinite vision distance setting, are both fully manually adjustable. The X81705 also has an automatic off/on functionality and digital readouts that can measure down to 0.5 nm.
The automated pupillometer market is expanding as more people seek alternatives to the traditional method of pupil measurement due to safety concerns. As an example, a 2016 study published in the American Journal of Critical Care found that neurological nurses and critical care consistently underestimated pupil size and incorrectly measured pupil reactivity, leading the authors to conclude that the use of an automated pupillometer medical device is an essential tool allowing for more effective and timely diagnostics.
The rising global incidence of eye problems is also fuelling demand for pupillometers. The number of people with moderate or severe visual impairment is projected to increase to nearly 588 million by 2050 from the current estimate of 217 million, according to 2017 research by the International Council of Ophthalmology.
The demand for pupillometers is expanding because of the rise in ophthalmic-related illnesses caused by prolonged use of digital electronics such as TVs, smartphones & tablets, laptops, video games, and PCs. While demand for pupilometers continues to rise, the market expansion is being stymied by a dearth of trained personnel to operate cutting-edge devices.
Principal Consultant
Pupillometer Market:
| Differentiating Aspects | Pupillometer Market |
|---|---|
| CAGR | 7.7% |
| Market Valuation in 2023 | US$ 385.56 Million |
| Projected Market Value in 2033 | US$ 809.56 Million |
| Drivers |
|
Ureteral Stents Market:
| Differentiating Aspects | Ureteral Stents Market |
|---|---|
| CAGR | 5.6% |
| Market Valuation in 2023 | US$ 498.2 Million |
| Projected Market Value in 2033 | US$ 907.21 Million |
| Drivers |
|
Surgical Microscopes Market:
| Differentiating Aspects | Surgical Microscopes Market |
|---|---|
| CAGR | 9.7% |
| Market Valuation in 2023 | US$ 1,096.8 Million |
| Projected Market Value in 2033 | US$ 2,301.6 Million |
| Drivers |
|
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
United States
| Market Share (2033) | 26.3% |
|---|
The US market is expected to hold a market share of 26.3% of the global market.
In 2021, North America accounted for over 26.3% of global revenue, thanks to the region's large population and high incidence of neurological and eye illnesses. Pupillometry's widespread applicability in the United States is another factor that should boost sales.
The United States is home to several market leaders, including NeurOptics, a company that designs and manufactures state-of-the-art pupillometers to improve medical diagnostics. The company is also investigating the application of pupillometers across a range of critical care settings to broaden the scope of its products.
Europe
| Market Growth Rate (2023 to 2033) | 8.8% |
|---|
An 8.8 percent compound annual growth rate (CAGR) is predicted for the Europe Pupillometer Market between 2023 and 2033.
As their use in neuropsychological testing becomes increasingly commonplace, pupillometers are enjoying brisk sales growth around the world. When compared to more conventional approaches, the price of the next-generation pupillometer is higher. Despite the advantages of medical devices, their adoption rate has not changed significantly in industrialized economies.
With the rising prevalence of neurological illnesses, the pupillometer is finding more and more uses. Furthermore, technical development has led to the creation of a pupillometer for the next generation, which is more advanced than the medical devices of the past.
Japan
The forecast calls for the fastest growth in Japan for the Asia Pacific region. Pupillometers are becoming more widely available in the region owing to an increase in the number of online retailers and distributors offering them. Pupillometers are also being offered by the regional branches of multinational corporations like NeurOptics, Johnson & Johnson Vision, and Konan Medical.
NeurOptics' pupillometer is available in India through Hansraj Nayyar Medical India, in Japan from IMI Co., and in South Korea from Neuroplus. The introduction of major corporations like NIDEK has boosted the automated pupillometer's accessibility and popularity in the region.
India
Pupillometry is a growing industry for many reasons, including the prevalence of neurological illnesses. According to The Lancet Global Health Report 2021, for instance, an aging population is a major contributor to the rising incidence of non-communicable neurological illnesses in India. Major causes of disability from neurological disorders in India include stroke, headache problems, and epilepsy. Since automated pupillometers are used to measure eye curvature, which can indicate neurological abnormalities, this drives up demand for the devices. Over the next few years, the market in question is likely to expand, thanks to the rising prevalence of neurological illnesses.
New Entrants to Foster Innovation in the Global Market
The startups in the pupillometer market are adding a new edge to the properties of excavators by curating innovations beyond the imagination. They are continually upgrading the pupillometer with advanced technology, and manufacturers and sellers are continuously attempting to reduce costs for greater accessibility to the market share. Startup firms are triggering the expansion of the pupillometer market with their unique attempts.
The top startups operating in the market are:
| Name | Mind’s Eye |
|---|---|
| Date of Establishment | 2016 |
| Description | When it comes to pupillometry biomarkers for ADHD, Mind'sEye Diagnostics has you covered. The platform relies on our novel scientific biomarkers, which include the use of a mobile phone camera to extract eye parameters, the execution of unique image analysis, and the deployment of a proprietary analysis algorithm, all of which allow for the identification of ADHD and other mental disorders. There's also a smartphone app that keeps tabs on how a patient's ADHD symptoms change throughout the day, allowing for more precise dosing and better overall management of the condition. |
| Name | EYE-COG |
|---|---|
| Mind’s Eye | 2016 |
| Description | EYE-main COG's goal is to aid in the identification of ADHD and other mental problems using pupillometry biomarkers. It has developed a platform that includes an Eye tracker, a short, computerized attention test, a personal questionnaire, and a cloud-based algorithm that analyses eye markers taken from the eye tracker data and automatically sends a full report to EYE-COG software which can be used for the accurate diagnosis of ADHD. Single ADHD analysis tests can be purchased for $30 each, and the kit can be purchased for $1500. |
There are several international and domestic players in the pupillometer industry, making for a competitive marketplace. NeurOptics Inc., Essilor Group (Essilor Instruments), Visionix, US Ophthalmic., NIDEK SA, HAAG-STREIT GROUP, Reichert Inc., Konan Medical USA Inc., Good-Lite Company, Grobet USA are among the top players in the market (Vigor Optical).
In order to maintain their market share and expand their product offerings, many companies are implementing market strategies like the introduction of new, ground-breaking items as well as mergers, collaborations, and acquisitions.
Some of the recent developments in the pupillometer market include the following:
NeurOptics Inc. introduced the NPi-300 pupillometer in 15 countries in May of 2022. The United Kingdom, France, Italy, Germany, Switzerland, Austria, Norway, Sweden, Denmark, Belgium, the Netherlands, Luxembourg, Ireland, Australia, and New Zealand were among the first to introduce the pupillometer.
The VERITAS Vision System, a next-generation phacoemulsification program (phaco) designed to address three critical areas of patient safety, performance during surgery, and comfort, became globally available on July 23, 2021, thanks to Johnson & Johnson Vision, a global leader in eye health and part of Johnson & Johnson Medical Devices Companies. This weekend at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) and American Society of Ophthalmic Administrators (ASOA) Meeting, the business is expected to provide live demonstrations of the innovative system in the wetland area of Johnson & Johnson.
In the United States, NeurOptics Inc. released the NPi-300 Pupillometer in July 2021. The NPI-300 is an automated pupillometer for use in neurological testing. It is also utilized to detect neurological disorders in both young and old individuals, including stroke, TBI, seizures, and other neurological events.
The growth outlook for the Pupillometer market is predicted to advance at a CAGR of 7.7% from 2022-to 2032.
The North American region is anticipated to lead the Pupillometer market during the forecast period.
The market valuation of the Pupillometer market stands at US$ 385.56 Mn Mn in 2023.
The Pupillometer market is likely to hold a valuation of U US$ 809.56 Mn by 2033.
The kitchen appliances sector is the key driver in the Pupillometer market.
1. Executive Summary | Pupillometer Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Mobility 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Mobility, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mobility, 2022 to 2032 5.3.1. Table-top 5.3.2. Hand-held 5.4. Y-o-Y Growth Trend Analysis By Mobility, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Mobility, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032 6.3.1. Video 6.3.2. Digital 6.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-Use 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By End-Use, 2017 to 2021 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-Use, 2022 to 2032 7.3.1. Hospitals 7.3.2. Eye Clinics 7.3.3. Others 7.4. Y-o-Y Growth Trend Analysis By End-Use, 2017 to 2021 7.5. Absolute $ Opportunity Analysis By End-Use, 2022 to 2032 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032 8.3.1. Ophthalmology 8.3.2. Neurology 8.3.3. Oncology 8.3.4. Others 8.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021 8.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. The US 10.2.1.2. Canada 10.2.2. By Mobility 10.2.3. By Type 10.2.4. By End-Use 10.2.5. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Mobility 10.3.3. By Type 10.3.4. By End-Use 10.3.5. By Application 10.4. Key Takeaways 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Mobility 11.2.3. By Type 11.2.4. By End-Use 11.2.5. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Mobility 11.3.3. By Type 11.3.4. By End-Use 11.3.5. By Application 11.4. Key Takeaways 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. The UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Mobility 12.2.3. By Type 12.2.4. By End-Use 12.2.5. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Mobility 12.3.3. By Type 12.3.4. By End-Use 12.3.5. By Application 12.4. Key Takeaways 13. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Mobility 13.2.3. By Type 13.2.4. By End-Use 13.2.5. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Mobility 13.3.3. By Type 13.3.4. By End-Use 13.3.5. By Application 13.4. Key Takeaways 14. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Mobility 14.2.3. By Type 14.2.4. By End-Use 14.2.5. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Mobility 14.3.3. By Type 14.3.4. By End-Use 14.3.5. By Application 14.4. Key Takeaways 15. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Mobility 15.2.3. By Type 15.2.4. By End-Use 15.2.5. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Mobility 15.3.3. By Type 15.3.4. By End-Use 15.3.5. By Application 15.4. Key Takeaways 16. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Mobility 16.2.3. By Type 16.2.4. By End-Use 16.2.5. By Application 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Mobility 16.3.3. By Type 16.3.4. By End-Use 16.3.5. By Application 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. The US 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2021 17.1.2.1. By Mobility 17.1.2.2. By Type 17.1.2.3. By End-Use 17.1.2.4. By Application 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2021 17.2.2.1. By Mobility 17.2.2.2. By Type 17.2.2.3. By End-Use 17.2.2.4. By Application 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2021 17.3.2.1. By Mobility 17.3.2.2. By Type 17.3.2.3. By End-Use 17.3.2.4. By Application 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2021 17.4.2.1. By Mobility 17.4.2.2. By Type 17.4.2.3. By End-Use 17.4.2.4. By Application 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2021 17.5.2.1. By Mobility 17.5.2.2. By Type 17.5.2.3. By End-Use 17.5.2.4. By Application 17.6. The UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2021 17.6.2.1. By Mobility 17.6.2.2. By Type 17.6.2.3. By End-Use 17.6.2.4. By Application 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2021 17.7.2.1. By Mobility 17.7.2.2. By Type 17.7.2.3. By End-Use 17.7.2.4. By Application 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2021 17.8.2.1. By Mobility 17.8.2.2. By Type 17.8.2.3. By End-Use 17.8.2.4. By Application 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2021 17.9.2.1. By Mobility 17.9.2.2. By Type 17.9.2.3. By End-Use 17.9.2.4. By Application 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2021 17.10.2.1. By Mobility 17.10.2.2. By Type 17.10.2.3. By End-Use 17.10.2.4. By Application 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2021 17.11.2.1. By Mobility 17.11.2.2. By Type 17.11.2.3. By End-Use 17.11.2.4. By Application 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2021 17.12.2.1. By Mobility 17.12.2.2. By Type 17.12.2.3. By End-Use 17.12.2.4. By Application 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2021 17.13.2.1. By Mobility 17.13.2.2. By Type 17.13.2.3. By End-Use 17.13.2.4. By Application 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2021 17.14.2.1. By Mobility 17.14.2.2. By Type 17.14.2.3. By End-Use 17.14.2.4. By Application 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2021 17.15.2.1. By Mobility 17.15.2.2. By Type 17.15.2.3. By End-Use 17.15.2.4. By Application 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2021 17.16.2.1. By Mobility 17.16.2.2. By Type 17.16.2.3. By End-Use 17.16.2.4. By Application 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2021 17.17.2.1. By Mobility 17.17.2.2. By Type 17.17.2.3. By End-Use 17.17.2.4. By Application 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2021 17.18.2.1. By Mobility 17.18.2.2. By Type 17.18.2.3. By End-Use 17.18.2.4. By Application 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2021 17.19.2.1. By Mobility 17.19.2.2. By Type 17.19.2.3. By End-Use 17.19.2.4. By Application 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2021 17.20.2.1. By Mobility 17.20.2.2. By Type 17.20.2.3. By End-Use 17.20.2.4. By Application 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2021 17.21.2.1. By Mobility 17.21.2.2. By Type 17.21.2.3. By End-Use 17.21.2.4. By Application 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Mobility 18.3.3. By Type 18.3.4. By End-Use 18.3.5. By Application 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. NeurOptics, Inc. 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. Adaptica 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Essilor Instruments USA 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. HAAG-STREIT GROUP 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Johnson & Johnson Vision 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Luneau Technology Group 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. NIDEK CO., LTD. 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Reichert Technologies 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. SCHWIND eye-tech-solutions 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. US Ophthalmic 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.11. Konan Medical 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.12. bright lamp, Inc. 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports
Pupillometer Market
